Academia

April 8th 2025

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell lung cancer (SCLC).

April 3rd 2025

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment strategies.

March 24th 2025

Inclusion of female and Hispanic/Latino patients has increased over time, but most trials of metabolic dysfunction-associated steatohepatitis (MASH) still take place in high-income countries and have majority-White patient populations.

March 20th 2025

Combining BET inhibitors and PARP inhibitors might help patients resistant to chemotherapy, the study suggests.